Literature DB >> 24795049

Improving antitubercular drug susceptibility testing with liquid media.

Sang Mee Hwang1, Kil Chae Hwang, Yun Ji Hong, Hye Ryun Lee, Taek Soo Kim, Kyoung Un Park, Junghan Song, Jae Ho Lee, Eui Chong Kim.   

Abstract

Liquid media such as the mycobacteria growth indicator tube (MGIT) are widely used for antitubercular drug susceptibility testing (DST) but may cause discordant or invalid results due to ordinary bacterial contamination or mixed mycobacterial colonies. To overcome the drawbacks of DST with MGIT (DSTMGIT), an experiment with a modified method that incorporated a subculture step on the Löwenstein-Jensen (LJ) media with positively identified liquid media of MGIT (modified DSTMGIT) was performed. For 307 samples identified as Mycobacterium tuberculosis complex from 2010 to 2012, DSTMGIT and modified DSTMGIT were performed for isoniazid, rifampin, streptomycin, and ethambutol using BACTEC MGIT 960. Those results were compared to the results of DST with the solid media, LJ (DSTLJ). We obtained drug susceptibility test results from 287 (93.5%) specimens; however, 20 (6.5%) specimens showed invalid results with error messages from the system using DSTMGIT. Thirteen (65.0%) of the 20 invalid DSTMGIT results were made valid using a modified form of DSTMGIT. DSTMGIT and the modified DSTMGIT methods had 41 (14.3%) discordant results to the reference method , DSTLJ. Also, five of these samples were falsely identified as multidrug-resistant. The percent of discordant results was similar between DSTMGIT and the modified DSTMGIT (P=0.624), but the bacterial contamination or mycobacterial mixture rate was significantly lower in the modified DSTMGIT (P=0.029). Modified DSTMGIT can reduce bacterial contamination or mixed mycobacterial cultures and can be useful for samples with discordant or invalid DST results.

Entities:  

Keywords:  Löwenstein-Jensen media; Mycobacterium tuberculosis complex; mycobacteria growth indicator tube

Mesh:

Substances:

Year:  2014        PMID: 24795049

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  4 in total

1.  Performance of WHO-Endorsed Rapid Tests for Detection of Susceptibility to First-Line Drugs in Patients with Pulmonary Tuberculosis in Bangladesh.

Authors:  S M Mazidur Rahman; Md Fahim Ather; Rumana Nasrin; Mohammad Ariful Hoque; Razia Khatun; Tanjina Rahman; Mohammad Khaja Mafij Uddin; Shahriar Ahmed; Sayera Banu
Journal:  Diagnostics (Basel)       Date:  2022-02-05

2.  Performance of QuantaMatrix Microfluidic Agarose Channel system integrated with mycobacteria growth indicator tube liquid culture.

Authors:  Hyejin Kim; Sangyeop Lee; EunJi Jo; Suyeoun Kim; Haeun Kim; Eun-Geun Kim; Sunghoon Kwon; Soyoun Shin
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-30       Impact factor: 4.813

3.  A Current Microbiological Picture of Mycobacterium Isolates from Istanbul, Turkey.

Authors:  Bilge Sumbul; Mehmet Ziya Doymaz
Journal:  Pol J Microbiol       Date:  2020

4.  Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs.

Authors:  Sangyeop Lee; Daehyun Chu; Youn Mi Choi; EunJi Jo; Suyeoun Kim; Haeun Kim; Hyun Jung Kim; Jeonghyun Chang; Heungsup Sung; Geumrae Kang; Bonghwan Jin; Eun-Geun Kim; Sunghoon Kwon; Mi-Na Kim
Journal:  Front Microbiol       Date:  2019-04-16       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.